In Treatment of Intermittent claudication Intermittent claudication refers to muscle pain on mild exertion (ache, cramp, numbness, or sense of fatigue), classically in the calf muscle, which occurs during exercise or even walking, and it gets better with a short period of rest. Stozic 50 Tablet helps relieve this pain in the legs that is caused due to disturbed blood supply in the legs. It helps prevent the formation of blood clots, improves blood flow, and maintains the free-flowing of blood in your body. Keep taking Stozic 50 Tablet as prescribed by the doctor to get maximum benefit.
It is not known whether it is safe to consume alcohol with Stozic 50 Tablet. Please consult your doctor.
Stozic 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Stozic 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Stozic 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Stozic 50 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Stozic 50 Tablet may be needed. Please consult your doctor.
Stozic 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Stozic 50 Tablet may be needed. Please consult your doctor. Use of Stozic 50 Tablet is not recommended in patients with moderate and severe liver disease as the information available in these patients is limited.
If you miss a dose of Stozic 50 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Integrace Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Curis Lifecare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Shinto Organics (P) Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Icon Life Sciences || ₹14.5/tablet (25% cheaper)